Clinical Trial Update: Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS) [NA]

View source ↗

Summary

A clinical trial is investigating ferroptosis-targeting approaches in SF3B1-mutant myelodysplastic syndromes, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Myelodysplastic Syndromes, Ferroptosis | NA | Status: RECRUITING